| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Aequus Pharmaceuticals Inc (V: AQS)
AQS Technical Analysis
4
| As on 8th Jun 2023 AQS STOCK Price closed @ 0.05 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.08 & Strong Sell for SHORT-TERM with Stoploss of 0.12 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AQSSTOCK Price
| Open | 0.04 | Change | Price | % |
| High | 0.05 | 1 Day | 0.01 | 25.00 |
| Low | 0.04 | 1 Week | 0.03 | 150.00 |
| Close | 0.05 | 1 Month | 0.02 | 66.67 |
| Volume | 19111 | 1 Year | -0.07 | -58.33 |
| 52 Week High 0.13 | 52 Week Low 0.02 | ||||
V Canada Most Active Stocks
| SNV | 0.06 | 100.00% |
| GDNP | 0.14 | -17.65% |
| NOCR | 0.02 | 0.00% |
| RHC | 0.34 | 0.00% |
| NHHH | 0.10 | 0.00% |
| VXTR | 0.17 | -5.56% |
| PGM | 0.02 | 0.00% |
| FOM | 3.23 | 3.86% |
| NBY | 0.08 | 0.00% |
| GXU | 0.15 | 0.00% |
V Canada Top Gainers Stocks
V Canada Top Losers Stocks
| AQS Daily Charts |
AQS Intraday Charts |
Whats New @ Bazaartrend |
AQS Free Analysis |
|
|
AQS Important Levels Intraday
| RESISTANCE | 0.07 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| RESISTANCE | 0.06 |
| SUPPORT | 0.04 |
| SUPPORT | 0.04 |
| SUPPORT | 0.04 |
| SUPPORT | 0.03 |
AQS Forecast May 2024
| 4th UP Forecast | 0.11 |
| 3rd UP Forecast | 0.09 |
| 2nd UP Forecast | 0.08 |
| 1st UP Forecast | 0.07 |
| 1st DOWN Forecast | 0.03 |
| 2nd DOWN Forecast | 0.02 |
| 3rd DOWN Forecast | 0.01 |
| 4th DOWN Forecast | -0.01 |
AQS Weekly Forecast
| 4th UP Forecast | 0.05 |
| 3rd UP Forecast | 0.05 |
| 2nd UP Forecast | 0.05 |
| 1st UP Forecast | 0.05 |
| 1st DOWN Forecast | 0.05 |
| 2nd DOWN Forecast | 0.05 |
| 3rd DOWN Forecast | 0.05 |
| 4th DOWN Forecast | 0.05 |
AQS Forecast2024
| 4th UP Forecast | 0.26 |
| 3rd UP Forecast | 0.19 |
| 2nd UP Forecast | 0.15 |
| 1st UP Forecast | 0.11 |
| 1st DOWN Forecast | -0.01 |
| 2nd DOWN Forecast | -0.05 |
| 3rd DOWN Forecast | -0.09 |
| 4th DOWN Forecast | -0.16 |
Aequus Pharmaceuticals Inc ( V Canada Symbol : AQS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AQS Business Profile
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantation. The company markets Vistitan, an ophthalmology product to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Tacrolimus IR, an immunosuppressant for the treatment and prevention of acute rejection following organ transplantation; Evolve dry eye products for various symptoms involved with dry eye disease and blepharitis, including discomfort, stinging, burning, and dryness; and preservative free ophthalmic product. Its development stage product includes Topiramate XR and Oxcarbazepine XR extended-release oral tablets for the treatment of epilepsy; AQS1303, a transdermal pyridoxine/doxylamine for the treatment of nausea and vomiting of pregnancy; and AQS1304, a cannabinoid based therapeutics for neurological disorders. The company has collaboration agreements with Sandoz Canada, Inc. for the promotion of Vistitan; Supernus Pharmaceuticals, Inc. for marketing of extended-release anti-epileptic drugs; and Medicom Healthcare Ltd. to focus on preservative free therapies in ophthalmology. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada. Address: 200 Granville Street, Vancouver, BC, Canada, V6C 1S4
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service